Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Vasculitis
Clinical narrative: is experiencing symptoms of Henoch-Schonlein Purpura (HSP), which consists of the inflammation of small blood vessels.; is experiencing symptoms of Henoch-Schonlein Purpura (HSP), which consists of the inflammation of small blood vessels.; About one week after the second Covid 19 vaccine the symptoms flared up again/Second dose: Henoch-Schonlein Purpura; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient's father).   A 16-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, batch/lot number: EW0179) via an unspecified route of administration, administered in left arm on 21May2021 (16-year-old at the time of vaccination) as dose 2, single dose for covid-19 immunization. Medical history included ongoing crohn's disease (only one in the family with Crohn's disease). Concomitant medication(s) included infliximab (REMICADE) taken for crohn's disease and somatropin (NUTROPIN) taken for blood growth hormone both the products from an unspecified start date and ongoing. The patient previously received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, batch/lot number: EW0176) via an unspecified route of administration, administered in arm left on 30Apr2021, as single dose for COVID-19 immunization and experienced Henoch-Schonlein Purpura, red blotches under his skin and blotches on his legs, vasculitis on his bowel, severe stomach pain and on his legs it looked like vasculitis. It was reported that on 21May2021 the patient received the second dose of vaccine and on an unspecified date in May2021 patient experienced symptoms of henoch-schonlein purpura (HSP), which consists of the inflammation of small blood vessels and one week after the dose of vaccine the symptoms of henoch-schonlein purpura flared up again and it can appear on the skin, intestines, joints and where small blood vessels started to leak. The reporter further stated that his son took the first dose of Covid-19 vaccine and developed Henoch-Schonlein Purpura (HSP) and stated as HSP is inflammation in the small blood vessels most commonly in children and it affects the skin, intestines and joints with leaking blood vessels. On his son's legs it looked like a vasculitis. His son had these red blotches under his skin. It didn't hurt. He also got vasculitis on his bowel. He had a colonoscopy to diagnosis the vasculitis on his bowel. His son was being treated with steroids. HSP was a chronic condition, and his son has been dealing with it from the last month. The doctor advised him to call Pfizer to report this information and to find out if there is data or any other complaints or notification for HSP from the Pfizer Covid 19 vaccine. He stated that patient does have other medical conditions as he had Crohn's disease and receives a Remicade infusion every 6 weeks, and he also takes Nutropin for growth hormones. When probing indication for receiving the Covid 19 vaccine he reports convenience because he would have to wear a mask here or there or answer if he's vaccinated or not vaccinated. He didn't decide to receive the Covid 19 vaccine in concerns of his health. He reported that patient never had a positive Covid 19 virus test, the PCR test or the Rapid test. The reporter thought that patient's symptoms began on or around 07May2021 after receiving the first Covid 19 vaccine and the symptoms subsided, and the doctor gave the ok to receive the second covid-19 vaccine. His symptoms did improve prior to the second Covid 19 vaccine. About one week after the second Covid 19 vaccine the symptoms flared up again. Now it's 23Jun2021 and he still has symptoms. He estimates his son was seen at the doctor on 04Jun2021 with a colonoscopy on 09Jun2021. The reporter also mentioned that If Pfizer reaches out to him he does have photographs of his son's legs he can share. He really does believe the HSP came from the Covid 19 vaccine, but that could be one in a million. He stated that he was not calling to discuss symptoms. On an unspecified date, the patient underwent lab tests and procedures which included blood test which result showed no abnormalities and urine analysis which result did showed blood which also indicates HSP, and on 09Jun2021 colonoscopy which result was unspecified. The outcome of all the events was not resolved.  Information on lot/batch number was available. Additional information has been requested.